Načítá se...
Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation
IL-18 is a crucial pro-inflammatory cytokine that mediates chronic intestinal inflammation. Metformin, an anti-diabetic drug, was reported to have ameliorative effects on inflammatory bowel disease. Recently, the mechanism of action of metformin was explained as a modulation of gut microbiota. In th...
Uloženo v:
| Vydáno v: | Immune Netw |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Association of Immunologists
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6722274/ https://ncbi.nlm.nih.gov/pubmed/31501716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2019.19.e28 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|